Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001663577-18-000342
Filing Date
2018-08-02
Accepted
2018-08-02 10:25:44
Documents
59
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 mainbody2.htm 10-K 397021
2 GRAPHIC image_002.jpg GRAPHIC 8371
3 ex31_1.htm EX-31.1 9084
4 ex31_2.htm EX-31.2 9084
5 ex32_1.htm EX-32.1 4024
  Complete submission text file 0001663577-18-000342.txt   1935062

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE vibi-20180331.xml EX-101.INS 217611
7 XBRL SCHEMA FILE vibi-20180331.xsd EX-101.SCH 41980
8 XBRL CALCULATION FILE vibi-20180331_cal.xml EX-101.CAL 20478
9 XBRL DEFINITION FILE vibi-20180331_def.xml EX-101.DEF 63216
10 XBRL LABEL FILE vibi-20180331_lab.xml EX-101.LAB 168092
11 XBRL PRESENTATION FILE vibi-20180331_pre.xml EX-101.PRE 145189
Mailing Address FABRIKSVEJ 48 NAESTVED G7 4700
Business Address FABRIKSVEJ 48 NAESTVED G7 4700 (646) 875-5747
Vilacto Bio Inc. (Filer) CIK: 0001576724 (see all company filings)

EIN.: 463883208 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 000-55023 | Film No.: 18987024
SIC: 7372 Services-Prepackaged Software